Predicted protein targets (top 10)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | GAA | P10253 | 1/20 | 0.34 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.34 |
| ▸ | PRKDC | P78527 | 2/20 | 0.34 |
| ▸ | PLA2G2A | P14555 | 2/20 | 0.33 |
| ▸ | PLA2G4A | P47712 | 2/20 | 0.33 |
| ▸ | MMP12 | P39900 | 2/20 | 0.33 |
| ▸ | MMP13 | P45452 | 1/20 | 0.33 |
| ▸ | PLA2G10 | O15496 | 1/20 | 0.33 |
| ▸ | PGR | P06401 | 1/20 | 0.32 |
| ▸ | HPSE | Q9Y251 | 1/20 | 0.32 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL21740648 | 0.98 | GAA (0.35) | GAAL3MBTL1PRKDCPLA2G2APLA2G4A | |
| SCHEMBL21668859 | 0.97 | PLA2G2A (0.33) | GAAL3MBTL1PRKDCPLA2G2APLA2G4A | |
| SCHEMBL21668702 | 0.97 | PLA2G2A (0.33) | GAAL3MBTL1PRKDCPLA2G2APLA2G4A | |
| SCHEMBL24216508 | 0.94 | L3MBTL1 (0.35) | GAAL3MBTL1PRKDCPLA2G2APLA2G4A | |
| SCHEMBL21883320 | 0.94 | L3MBTL1 (0.35) | GAAL3MBTL1PRKDCPLA2G2APLA2G4A | |
| SCHEMBL21669202 | 0.94 | L3MBTL1 (0.35) | GAAL3MBTL1PRKDCPLA2G2APLA2G4A | |
| SCHEMBL21883359 | 0.94 | L3MBTL1 (0.35) | GAAL3MBTL1PRKDCPLA2G2APLA2G4A | |
| SCHEMBL25926900 | 0.94 | L3MBTL1 (0.35) | GAAL3MBTL1PRKDCPLA2G2APLA2G4A | |
| SCHEMBL21669156 | 0.94 | L3MBTL1 (0.35) | GAAL3MBTL1PRKDCPLA2G2APLA2G4A | |
| SCHEMBL25926910 | 0.94 | PLA2G2A (0.35) | GAAL3MBTL1PRKDCPLA2G2APLA2G4A |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-11785844-B2 | Organic light emitting device, method for manufacturing same and composition for organic material layer | LT MATERIALS CO., LTD. (KR) | 2023-10-10 | — | — | US | disclosed |
| US-11785844-B2 | Organic light emitting device, method for manufacturing same and composition for organic material layer | LT MATERIALS CO., LTD. (KR) | 2023-10-10 | — | — | US | disclosed |
| US-11387418-B2 | Organic light emitting element and composition for organic material layer in organic light emitting element | LT MATERIALS CO., LTD. (KR) | 2022-07-12 | — | — | US | disclosed |
| US-20210057651-A1 | ORGANIC LIGHT EMITTING DEVICE, METHOD FOR MANUFACTURING SAME AND COMPOSITION FOR ORGANIC MATERIAL LAYER | LT MATERIALS CO., LTD. (KR) | 2021-02-25 | — | — | US | disclosed |
| US-20200381629-A1 | HETEROCYCLIC COMPOUND AND ORGANIC LIGHT EMITTING ELEMENT COMPRISING SAME | LT MATERIALS CO., LTD. (KR) | 2020-12-03 | — | — | US | disclosed |
| US-20200119285-A1 | ORGANIC LIGHT EMITTING ELEMENT AND COMPOSITION FOR ORGANIC MATERIAL LAYER IN ORGANIC LIGHT EMITTING ELEMENT | HEESUNG MATERIAL LTD. (KR) | 2020-04-16 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-11387418-B2 | Organic light emitting element and composition for organic material layer in organic light emitting element | CRY1, CYBA, L1CAM | GAA 3543/4885L3MBTL1 838/4885PRKDC 4167/4885 |
| US-20200119285-A1 | ORGANIC LIGHT EMITTING ELEMENT AND COMPOSITION FOR ORGANIC MATERIAL LAYER IN ORGANIC LIGHT EMITTING ELEMENT | CRY1, CYBA, L1CAM | GAA 3543/4885L3MBTL1 838/4885PRKDC 4167/4885 |
| US-20200381629-A1 | HETEROCYCLIC COMPOUND AND ORGANIC LIGHT EMITTING ELEMENT COMPRISING SAME | CRY1, CRY2, CYP1A1 | GAA 2415/4885L3MBTL1 1142/4885PRKDC 4595/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.